A new market-oriented approach to product development, more
favourable licensing arrangements, strategic acquisitions and a
fresh crop of proprietary drug-delivery technologies helped UK
company BioProgress to deliver an adjusted...
UK-based firm BioProgress has developed novel tablet cores that
mean pills which were previously very difficult to coat can be
reformulated and easily coated using the company's innovative
TabWrap technology.
Speciality pharma company Bioprogress has launched new anti-snoring
and caffeine products based on its edible film drug delivery
technology, offering an effective alternative to conventional
formulations.
BioProgress has allowed the exclusive partnership with US drugmaker
Wyeth on over-the-counter applications of its SWOLLO oral dosage
form technology to lapse, reports Phil Taylor.
BioProgress of the UK, which makes cellulose based films for
coating tablets and capsules, is planning to buy a company which
would provide a rapid route to increase production capacity in the
US, and also accelerate the development...
BioProgress has completed the design and build of the first pilot
scale version of its XGEL NROBE powdered drug coating technology
and is set to deliver the machine to Farmasierra in Madrid, Spain.